陈家祈, 王丽, 朴春丽. 玉液汤联合二甲双胍治疗2型糖尿病Meta分析. 2024. biomedRxiv.202407.00066
玉液汤联合二甲双胍治疗2型糖尿病Meta分析
通讯作者: 朴春丽, pcl2013@sina.cn
DOI:10.12201/bmr.202407.00066
Efficacy and safety of Yuye decoction with metformin in type 2 diabetes mellitus: A meta-analysis
Corresponding author: PIAO Chun-li, pcl2013@sina.cn
-
摘要:目的:旨在系统评价玉液汤联合二甲双胍治疗2型糖尿病(type 2 diabetes mellitus,T2DM)的有效性与安全性,为制定T2DM患者的降糖方案提供参考依据。 方法:通过检索中国知网、万方、维普、中国生物医学文献数据库、PubMed、EMbase、Cochrane Library、Web of Science 8个中英文数据库,收集玉液汤联合二甲双胍治疗T2DM的随机对照试验(randomized controlled trial,RCT)。使用Cochrane评价手册5.3风险偏倚评估工具对文献进行质量评价,采用RevMan 5.4.1统计软件进行数据分析与异质性检验,主要结局指标为糖化血红蛋白(glycated hemoglobin A1c,HbA1c),次要结局指标为胰岛素抵抗指数(homeostatic model assessment for insulin resistance,HOMA-IR)、总胆固醇(total cholesterol,TC)、临床有效率及不良反应率。结果:①经筛选后,最后纳入10项RCTs进行Meta分析。②Meta分析显示,试验组HbA1c(MD=-0.92,95%CI-1.58,-0.26)、HOMA-IR(MD=-0.14,95%CI-0.59,0.32)、TC(MD=-0.83,95%CI-1.95,0.29)及临床有效率(OR=3.73,95%CI2.25,6.18)改善方面均优于对照组,差异有统计学意义(P < 0.05)。在不良反应发生率方面,试验组与对照组无明显差异(P> 0.05)。结论:玉液汤联合二甲双胍可改善糖脂代谢、胰岛素抵抗,延缓糖尿病的发展,目前尚未发现严重不良反应。但未来仍需要进行大样本、多中心、双盲、高质量的RCTs以验证有关结论。
Abstract: Objectives: To access the efficacy and safety of Yuye decoction with metformin in the treatment of type 2 diabetes mellitus (T2DM).Methods: A total of 8 databases including CNKI, SinoMed, Wanfang, VIP, Cochrane Library, PubMed, EMbase and Web of Science were retrieved for randomized controlled trial (RCT) of Yuye decoction in the treatment of T2DM. Cochrane handbook 5.3 was used to evaluate the quality of the included studies. RevMan 5.4.1 were employed to analyze data and test heterogeneity. The primary outcome was glycated hemoglobin A1c(HbA1c). Secondary outcomes include homeostatic model assessment for insulin resistance(HOMA-IR),total cholesterol(TC),clinical effective rate and adverse event rate.Results: A total of 10 RCTs were included in the final meta-analysis. The meta-analysis revealed that the improvements of HbA1c(MD=-0.92,95%CI-1.58,-0.26), HOMA-IR(MD=-0.14,95%CI-0.59,0.32),TC(MD=-0.83,95%CI-1.95,0.29)and clinical effective rate(OR=3.73,95%CI2.25,6.18) in the experimental group were better than those in the control group(P < 0.05). There was no serious adverse effects being observed in both experimental group and control group. Conclusions: The combination of Yuye decoction and metformin could improve blood glucose and lipid profile as well as reduce insulin resistance, and no serious adverse reactions were observed yet. Further validation in the future is required through large-sample, multi-centered and high quality RCTs.
Key words: Yuye decoction; type 2 diabetes mellitus; clinical trials; systematic review; meta-analysis提交时间:2024-07-29
版权声明:作者本人独立拥有该论文的版权,预印本系统仅拥有论文的永久保存权利。任何人未经允许不得重复使用。 -
图表
-
俞红, 王从容, 陈方, 殷善开, 胡承, 包玉倩, 贾伟平, 张良, 朱琳. 基于知识图谱的2型糖尿病健康教育研究. 2020. doi: 10.12201/bmr.202007.00001
王涛. 门诊老年2型糖尿病患者低血糖的危险因素分析. 2024. doi: 10.12201/bmr.202412.00069
李瑞瑶, 许婧怡, 戴浩宇, 孙慧文, 鲍瀛, 华履春, 吴天星. 基于深度置信网络的2型糖尿病微血管并发症预测. 2024. doi: 10.12201/bmr.202404.00021
王一凡, 石超君, 马安宁. Ⅱ型糖尿病并发动脉粥样硬化风险预测模型比较. 2024. doi: 10.12201/bmr.202404.00007
彭湾湾, 薛君力, 曾姣娥. 多格列艾汀联合二甲双胍治疗初发超重及肥胖2型糖尿病. 2024. doi: 10.12201/bmr.202409.00035
王楠, 王国蓉, 施雯停, 李清炉. 维持性血液透析患者皮肤瘙痒影响因素的系统评价和Meta分析. 2024. doi: 10.12201/bmr.202410.00043
薄春燕, 张仕佩, 楚金申, 薛国辉, 万芳, 曹俊达, 陈可奇, 陈静, 刘晓峰, 陈雪礼. 2型糖尿病患者血清人附睾分泌蛋白4与蛋白尿的相关性研究. 2024. doi: 10.12201/bmr.202409.00008
郑敏瑶, 楚鑫, 何艳, 李娜娜. 糖尿病患者足部自我护理行为影响因素的Meta分析. 2024. doi: 10.12201/bmr.202408.00046
梁登耀, 刘师伟. NLR、PLR对2型糖尿病肾病的预测价值. 2024. doi: 10.12201/bmr.202408.00066
白晶雪, 雷根平, 王婷, 董盛, 谢炯东, 陆娴, 杨东. 中药复方治疗特发性膜性肾病的安全性及有效性网状Meta分析. 2024. doi: 10.12201/bmr.202412.00003
-
序号 提交日期 编号 操作 1 2024-06-24 bmr.202407.00066V1
下载 -
-
公开评论 匿名评论 仅发给作者
引用格式
访问统计
- 阅读量:246
- 下载量: 0
- 评论数:0